{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:42:31Z","timestamp":1764225751854,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006098","name":"RSNA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.cllc.2022.01.006","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T02:33:08Z","timestamp":1643941988000},"page":"282-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Detection of Recurrence After Thoracic Stereotactic Ablative Radiotherapy Using FDG-PET-CT"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9469-1388","authenticated-orcid":false,"given":"Quaovi H.","family":"Sodji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy P.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4011-3387","authenticated-orcid":false,"given":"Andrew","family":"Quon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie A.","family":"Modlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brianna","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1857-0680","authenticated-orcid":false,"given":"Alice","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Trakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8244-2042","authenticated-orcid":false,"given":"Peter G.","family":"Maxim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2032-0581","authenticated-orcid":false,"given":"Maximilian","family":"Diehn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Billy W.","family":"Loo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4723-2151","authenticated-orcid":false,"given":"Susan M.","family":"Hiniker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2022.01.006_bib0001","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cllc.2022.01.006_bib0002","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.cllc.2022.01.006_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2022.01.006_bib0004","unstructured":"Network., N.C. C. Non-Small Cell Lung Cancer (Version 3.2020). https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx#nscl (accessed March 19, 2020)."},{"key":"10.1016\/j.cllc.2022.01.006_bib0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.radonc.2011.12.018","article-title":"Radiographic changes after lung stereotactic ablative radiotherapy (SABR) \u2013 can we distinguish recurrence from fibrosis? A systematic review of the literature","volume":"102","author":"Huang","year":"2012","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.cllc.2022.01.006_bib0006","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/JTO.0b013e318219aac5","article-title":"Radiological changes after stereotactic radiotherapy for stage I lung cancer","volume":"6","author":"Dahele","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.cllc.2022.01.006_bib0007","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/JTO.0b013e31815e6d6b","volume":"3","author":"Berghmans","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2022.01.006_bib0008","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00259-010-1706-8","article-title":"18F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot study","volume":"38","author":"Wiegman","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cllc.2022.01.006_bib0009","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.lungcan.2006.12.009","article-title":"FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer","volume":"56","author":"Hoopes","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2022.01.006_bib0010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ijrobp.2009.02.051","article-title":"A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy","volume":"76","author":"Henderson","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2022.01.006_bib0011","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.lungcan.2012.11.008","article-title":"Evaluation for local failure by 18F-FDG PET\/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer","volume":"79","author":"Takeda","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2022.01.006_bib0012","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12149-012-0682-4","article-title":"Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET\/CT findings","volume":"27","author":"Nakajima","year":"2013","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.cllc.2022.01.006_bib0013","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jtcvs.2012.12.024","article-title":"Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer","volume":"145","author":"Ebright","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2022.01.006_bib0014","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1378\/chest.13-2281","article-title":"Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer","volume":"146","author":"Pastis","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2022.01.006_bib0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejca.2015.11.018","article-title":"A systematic review on [18F]FLT-PET uptake as a measure of treatment response in cancer patients","volume":"55","author":"Bollineni","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cllc.2022.01.006_bib0016","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3389\/fonc.2019.00467","article-title":"FLT-PET-CT for the detection of disease recurrence after stereotactic ablative radiotherapy or hyperfractionation for thoracic malignancy: a prospective pilot study","volume":"9","author":"Hiniker","year":"2019","journal-title":"Front Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730422000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730422000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:12:52Z","timestamp":1761505972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730422000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1525730422000109"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2022.01.006","relation":{},"ISSN":["1525-7304"],"issn-type":[{"type":"print","value":"1525-7304"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of Recurrence After Thoracic Stereotactic Ablative Radiotherapy Using FDG-PET-CT","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2022.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}